Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group

Affiliations

• ¹ Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
• ² Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA, USA.
• ³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ⁴ Broad Institute, Cambridge, MA, USA.
• ⁵ Center for Childhood Cancer and Blood Diseases at Nationwide Children's Hospital Research Institute and the Division of Pediatric Heme/Onc/BMT at The Ohio State University, Columbus, OH, USA.
• ⁶ Department of Pediatrics, MD Anderson Cancer Center, Houston, TX, USA.
• ⁷ Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.
• ⁸ Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
• ⁹ Department of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, CA, USA.
• ¹⁰ Children's Oncology Group, Monrovia, CA, USA.
• ¹¹ Department of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
• ¹² Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA. [email protected].
• ¹³ Broad Institute, Cambridge, MA, USA. [email protected].
• ¹⁴ Department of Pediatric Oncology, 450 Brookline Avenue, Boston, MA, USA. [email protected].